Get In Touch

Colon carcinoma is one of the most commonly occurring cancer type around the globe, it is usually developed in parts of the large intestine such as colon or rectum. The underlining cause of the cancer is an abnormal growth of cells in the parts of the large intestine due to certain cellular mutation. These cancer cells often lead to the growth of tumor in the respective area and are capable of invading other parts of the body. People over the age of 50 are more prone to the disease as incidence ratio is high amongst the geriatric population. Higher consumption of junked food, red meat and processed meat and lack of physical activity are linked with colon carcinoma. Health experts also suggest obesity, excessive smoking and consumption of alcohol as other factors that may cause the disease. 

Few of the symptoms include blood in the stool, abnormal bowel movements, constipation weakness, vomiting, weight loss and nausea. At times, colon carcinoma may also root other complications such as inflammatory bowel disorders.

Higher emphasis on further development of anti-carcinogenic drugs is expected to deliver some promising outcomes in the near future.  Currently, colon carcinoma has four common treatment modules namely chemotherapy, immunotherapy, targeted therapy and laparoscopic surgery. In the recent years, laparoscopic surgery has become more popular as the treatment is less painful delivering greater results.

Increasing Incidence Rate and Higher Demand of Cancer Therapeutics is expected to drive the Global Colon Carcinoma Therapeutics Market 

Increasing geriatric population and changing lifestyle are the major cause of the disease. Being one of the most commonly occurring cancers, the demand for its treatment is growing at a significant rate. Further, increasing awareness and early diagnosis are expected to fuel the global colon carcinoma therapeutics market in the near future. The demand for anti-carcinogenic drugs and therapies in many of the Asian countries is growing at a healthy pace and is expected to favor the overall market. With each coming year, the number of incidences is increasing and is considered as a major factor driving the global market.

On the other hand, despite increasing research and medicinal advancements, a complete cure for the disease is still not available. Biomedical researchers, scientist and health experts have seen success in extending the life expectancy of the patients, however, mortality rate still remains high in most cases. Other factors curtailing the growth of the market include high-cost of treatment, adverse side effects and credibility of drugs. Apart from these, long durations of research and heavy financial investments required for conducting preclinical research and development programs are major concerns for the pharmaceutical companies supplying colon carcinoma drugs.  

Most patients receiving cancer treatments are subjected to severe side effects such as weight loss, hair loss and extreme weakness. Hence, drug manufacturers are highly focusing on enhancing the conventional methods of treatment. Over the past few years, a range of novel anti-carcinogenic drugs has introduced in the market by different brands. Furthermore, advanced screening test and surgery techniques such as robotic surgery has come up and are considered beneficial for the global colon carcinoma therapeutics market in the coming years.

Colon Carcinoma Therapeutics Market: Regional Segmentation

On the basis of region, the global colon carcinoma therapeutics market has been segmented into six key regions namely North America, Western Europe, Eastern Europe, Latin America, Asia Pacific (APAC), and the Middle East & Africa (MEA). North America is considered one of the largest markets of colon carcinoma therapeutics. In addition, the U.S. accounted for more than one million new cases of colon carcinoma in 2015 and the number is expected to increase with each coming year. 

Key Players

Few of the key players identified in the global colon carcinoma therapeutics market include Novartis International AG, F. Hoffmann-La Roche AG, AMGen, Celgene Corporation, Bristol-Myers Squibb, Merck & Co., Inc.

This study by TMR is all-encompassing framework of the dynamics of the market. It mainly comprises critical assessment of consumers' or customers' journeys, current and emerging avenues, and strategic framework to enable CXOs take effective decisions.

Our key underpinning is the 4-Quadrant Framework EIRS that offers detailed visualization of four elements:

  • Customer Experience Maps
  • Insights and Tools based on data-driven research
  • Actionable Results to meet all the business priorities
  • Strategic Frameworks to boost the growth journey

The study strives to evaluate the current and future growth prospects, untapped avenues, factors shaping their revenue potential, and demand and consumption patterns in the global market by breaking it into region-wise assessment.

The following regional segments are covered comprehensively:

  • North America
  • Asia Pacific
  • Europe
  • Latin America
  • The Middle East and Africa

The EIRS quadrant framework in the report sums up our wide spectrum of data-driven research and advisory for CXOs to help them make better decisions for their businesses and stay as leaders.

Below is a snapshot of these quadrants.

1. Customer Experience Map

The study offers an in-depth assessment of various customers’ journeys pertinent to the market and its segments. It offers various customer impressions about the products and service use. The analysis takes a closer look at their pain points and fears across various customer touchpoints. The consultation and business intelligence solutions will help interested stakeholders, including CXOs, define customer experience maps tailored to their needs. This will help them aim at boosting customer engagement with their brands.

2. Insights and Tools

The various insights in the study are based on elaborate cycles of primary and secondary research the analysts engage with during the course of research. The analysts and expert advisors at TMR adopt industry-wide, quantitative customer insights tools and market projection methodologies to arrive at results, which makes them reliable. The study not just offers estimations and projections, but also an uncluttered evaluation of these figures on the market dynamics. These insights merge data-driven research framework with qualitative consultations for business owners, CXOs, policy makers, and investors. The insights will also help their customers overcome their fears.

3. Actionable Results

The findings presented in this study by TMR are an indispensable guide for meeting all business priorities, including mission-critical ones. The results when implemented have shown tangible benefits to business stakeholders and industry entities to boost their performance. The results are tailored to fit the individual strategic framework. The study also illustrates some of the recent case studies on solving various problems by companies they faced in their consolidation journey.

4. Strategic Frameworks

The study equips businesses and anyone interested in the market to frame broad strategic frameworks. This has become more important than ever, given the current uncertainty due to COVID-19. The study deliberates on consultations to overcome various such past disruptions and foresees new ones to boost the preparedness. The frameworks help businesses plan their strategic alignments for recovery from such disruptive trends. Further, analysts at TMR helps you break down the complex scenario and bring resiliency in uncertain times.

The report sheds light on various aspects and answers pertinent questions on the market. Some of the important ones are:

1. What can be the best investment choices for venturing into new product and service lines?

2. What value propositions should businesses aim at while making new research and development funding?

3. Which regulations will be most helpful for stakeholders to boost their supply chain network?

4. Which regions might see the demand maturing in certain segments in near future?

5. What are the some of the best cost optimization strategies with vendors that some well-entrenched players have gained success with?

6. Which are the key perspectives that the C-suite are leveraging to move businesses to new growth trajectory?

7. Which government regulations might challenge the status of key regional markets?

8. How will the emerging political and economic scenario affect opportunities in key growth areas?

9. What are some of the value-grab opportunities in various segments?

10. What will be the barrier to entry for new players in the market?

Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.

Custom Market Research Services

TMR offers custom market research services that help clients to get information on their business scenario required where syndicated solutions are not enough.


Colon Carcinoma Therapeutics Market